Our mission is to provide a highly differentiated minimally-invasive surgical solution designed to customize the visual outcome of the pseudophakic eye. Primary product is the AccuraSee Intraocular Pseudophakic Contact Lens (IOPCL) invented by Kevin Cady, CEO and Founder of OnPoint Vision, Inc.
Company’s Keywords:
ophthalmic surgical device, intraocular lenses, customized pseudophakic vision, treatment for age related macular degeneration, ophthalmology
<4
<
<
<2019